IL154419A0 - The treatment of inflammatory disorders - Google Patents

The treatment of inflammatory disorders

Info

Publication number
IL154419A0
IL154419A0 IL15441901A IL15441901A IL154419A0 IL 154419 A0 IL154419 A0 IL 154419A0 IL 15441901 A IL15441901 A IL 15441901A IL 15441901 A IL15441901 A IL 15441901A IL 154419 A0 IL154419 A0 IL 154419A0
Authority
IL
Israel
Prior art keywords
treatment
inflammatory disorders
inflammatory
mefloquine
administration
Prior art date
Application number
IL15441901A
Other languages
English (en)
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arakis Ltd filed Critical Arakis Ltd
Publication of IL154419A0 publication Critical patent/IL154419A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15441901A 2000-09-05 2001-08-31 The treatment of inflammatory disorders IL154419A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0021776.0A GB0021776D0 (en) 2000-09-05 2000-09-05 The treatment of inflammatory disorders
PCT/GB2001/003924 WO2002019994A2 (en) 2000-09-05 2001-08-31 The treatment of inflammatory disorders

Publications (1)

Publication Number Publication Date
IL154419A0 true IL154419A0 (en) 2003-09-17

Family

ID=9898880

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15441901A IL154419A0 (en) 2000-09-05 2001-08-31 The treatment of inflammatory disorders

Country Status (22)

Country Link
US (2) US7034028B2 (pt)
EP (1) EP1315496B1 (pt)
JP (1) JP2004508323A (pt)
CN (1) CN1309388C (pt)
AT (1) ATE302008T1 (pt)
AU (2) AU8423401A (pt)
BR (1) BR0113646A (pt)
CA (1) CA2419601A1 (pt)
DE (1) DE60112768T2 (pt)
DK (1) DK1315496T3 (pt)
ES (1) ES2245372T3 (pt)
GB (1) GB0021776D0 (pt)
HK (1) HK1054324A1 (pt)
HU (1) HUP0300934A2 (pt)
IL (1) IL154419A0 (pt)
MX (1) MXPA03001920A (pt)
NO (1) NO323227B1 (pt)
NZ (1) NZ524099A (pt)
PL (1) PL364030A1 (pt)
PT (1) PT1315496E (pt)
WO (1) WO2002019994A2 (pt)
ZA (1) ZA200301139B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021776D0 (en) * 2000-09-05 2000-10-18 Arakis Ltd The treatment of inflammatory disorders
GB0406014D0 (en) * 2004-03-17 2004-04-21 Arakis Ltd Pharmaceutical composition and use
WO2006108666A1 (en) * 2005-04-13 2006-10-19 Proteosys Ag Mefloquine, nelfinavir and saquinavir as novel agents for neurodegenerative and (neuro-) inflammatory diseases
US20100144827A1 (en) * 2006-12-20 2010-06-10 Medwell Laboratories Ltd. C/O Ngt Technological Incubator Novel conjugates of polyunsaturated fatty acids with amines and therapeutic uses thereof
AU2011276349A1 (en) * 2010-07-07 2013-02-28 Polymedix, Inc. Methods of immune modulation
CN113578299B (zh) * 2020-04-30 2023-11-10 中国石油化工股份有限公司 一种硅铝锆复合氧化物、催化裂化催化剂及其制备方法和应用
CN114452289B (zh) * 2020-12-31 2023-06-09 兰州大学 喹啉类衍生物在制备预防和/或治疗胃肠道疾病药物中的应用
CN114796216A (zh) * 2022-01-04 2022-07-29 南京医科大学 甲氟喹在防治全身代谢性炎症疾病中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68914990T2 (de) * 1988-06-30 1994-08-11 Michael H Davis Verfahren zur inhibierung der wirkung des menschlichen immunschwäche-virus (hiv) in vivo.
SK280617B6 (sk) * 1992-01-16 2000-05-16 Hoechst Aktiengesellschaft Arylcykloalkylové deriváty, spôsob ich prípravy, f
NZ278667A (en) * 1994-03-09 2000-12-22 Pfizer Use of isoxazoline derivatives to inhibit TNF production
PT966285E (pt) 1997-03-07 2002-12-31 Vernalis Res Ltd Utilizacao de (+)mefloquina para o tratamento da malaria
US6197788B1 (en) * 1997-11-26 2001-03-06 Vernalis Research Limited (−)-mefloquine to block puringergic receptors and to treat movement or neurodegenerative disorders
CA2372443C (en) * 1999-04-30 2010-07-13 Apt Pharmaceuticals, L.L.C. Local administration of anti-malarial agents for the treatment of inflammatory diseases
GB0021776D0 (en) * 2000-09-05 2000-10-18 Arakis Ltd The treatment of inflammatory disorders

Also Published As

Publication number Publication date
NO20030985L (no) 2003-03-03
HUP0300934A2 (hu) 2003-11-28
NO20030985D0 (no) 2003-03-03
ATE302008T1 (de) 2005-09-15
ES2245372T3 (es) 2006-01-01
CN1452488A (zh) 2003-10-29
WO2002019994A2 (en) 2002-03-14
HK1054324A1 (en) 2003-11-28
US7034028B2 (en) 2006-04-25
EP1315496A2 (en) 2003-06-04
NZ524099A (en) 2004-04-30
US20060074106A1 (en) 2006-04-06
PT1315496E (pt) 2005-11-30
MXPA03001920A (es) 2004-02-12
CN1309388C (zh) 2007-04-11
GB0021776D0 (en) 2000-10-18
DE60112768T2 (de) 2006-02-02
AU2001284234B2 (en) 2004-11-04
DK1315496T3 (da) 2005-11-14
CA2419601A1 (en) 2002-03-14
WO2002019994A3 (en) 2002-05-16
PL364030A1 (en) 2004-12-13
ZA200301139B (en) 2004-03-29
EP1315496B1 (en) 2005-08-17
BR0113646A (pt) 2004-01-06
JP2004508323A (ja) 2004-03-18
DE60112768D1 (de) 2005-09-22
US20040029916A1 (en) 2004-02-12
NO323227B1 (no) 2007-02-05
AU8423401A (en) 2002-03-22

Similar Documents

Publication Publication Date Title
AP2004003026A0 (en) Methods for treating ocular neovascular diseases.
ES2168006T3 (es) Factor neurotrofico ciliar modificado, metodo de fabricacion y metodos de utilizacion.
PL362690A1 (en) Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders
HRP20020593B1 (en) Brain, spinal and nerve injury treatment
MXPA03002814A (es) Derivados de morfolin-acetamida para el tratamiento de enfermedades inflamatorias.
AU5093399A (en) Hemofiltration systems, methods, and devices used to treat inflammatory mediatorrelated disease
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
HK1051690A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
IL154419A0 (en) The treatment of inflammatory disorders
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
TR200200278T2 (tr) Kalsilitik bileşimler
MXPA03004017A (es) Metodo para el tratamiento de inflamacion.
MXPA01011720A (es) 3-piridil-4-arilpirroles sustituidos, y metodos terapeuticos y profilacticos relacionados.
MXPA03003032A (es) Terapia de combinacion para el tratamiento de una enfermedad sensible a los estrogenos.
HK1047695A1 (en) Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina
PT1212119E (pt) Utilizacao de ciamemazina no tratamento do desmame subito de benzodiazepinas
ZA991783B (en) Therapeutic treatment for autoimmune diseases.
EP1409041A4 (en) HEMOFILTRATION SYSTEMS, METHODS AND DEVICES FOR THE TREATMENT OF DISEASES RELATED TO INFLAMMATION MEDIATORS
WO2000051585A3 (en) Use of a non-naturally-occurring ep1 selective agonist for increasing bone volume
ZA200101103B (en) Integrated wastewater treatment process.
NZ517348A (en) Use of a mycobacterial extract in the treatment of inflammatory bowel disease
AP2000001958A0 (en) Paroxetine 10-camphorsulfornate for treatment of CNS disorders.
木村留美子 et al. The influence of experience on nurse self-evaluation, in the context of self-imag ePart1
ZA200304439B (en) Therapeutic treatment.